13,830 Shares in Phibro Animal Health Co. (NASDAQ:PAHC) Acquired by Hsbc Holdings PLC

Hsbc Holdings PLC bought a new stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) in the 2nd quarter, HoldingsChannel reports. The firm bought 13,830 shares of the company’s stock, valued at approximately $238,000.

Other large investors have also recently added to or reduced their stakes in the company. CWM LLC boosted its stake in shares of Phibro Animal Health by 89.8% during the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after acquiring an additional 1,035 shares in the last quarter. Fidelis Capital Partners LLC acquired a new position in shares of Phibro Animal Health in the 1st quarter valued at $46,000. China Universal Asset Management Co. Ltd. boosted its position in shares of Phibro Animal Health by 65.0% in the 1st quarter. China Universal Asset Management Co. Ltd. now owns 3,888 shares of the company’s stock valued at $50,000 after purchasing an additional 1,531 shares during the period. Summit Securities Group LLC purchased a new position in Phibro Animal Health in the 2nd quarter worth about $83,000. Finally, Illinois Municipal Retirement Fund raised its holdings in Phibro Animal Health by 7.2% during the 1st quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock worth $148,000 after buying an additional 765 shares during the period. 99.34% of the stock is currently owned by institutional investors.

Phibro Animal Health Price Performance

Shares of PAHC opened at $21.31 on Friday. The business’s 50-day moving average is $20.04 and its 200-day moving average is $17.52. The company has a debt-to-equity ratio of 1.79, a current ratio of 2.94 and a quick ratio of 1.64. The company has a market capitalization of $863.12 million, a price-to-earnings ratio of 66.59, a P/E/G ratio of 1.77 and a beta of 0.52. Phibro Animal Health Co. has a fifty-two week low of $9.40 and a fifty-two week high of $22.84.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. The company had revenue of $273.16 million during the quarter, compared to the consensus estimate of $262.44 million. Phibro Animal Health had a net margin of 0.24% and a return on equity of 18.08%. Equities research analysts expect that Phibro Animal Health Co. will post 1.44 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Wednesday, September 4th were paid a $0.12 dividend. The ex-dividend date was Wednesday, September 4th. This represents a $0.48 dividend on an annualized basis and a yield of 2.25%. Phibro Animal Health’s dividend payout ratio (DPR) is currently 150.00%.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on PAHC shares. Bank of America lifted their target price on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price objective on the stock. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $15.00.

Insiders Place Their Bets

In other news, Director E Thomas Corcoran purchased 5,000 shares of Phibro Animal Health stock in a transaction dated Wednesday, September 4th. The stock was acquired at an average cost of $20.02 per share, for a total transaction of $100,100.00. Following the acquisition, the director now directly owns 25,000 shares in the company, valued at $500,500. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 50.06% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.